TBX3 Promotes Cervical Cancer Proliferation and Migration via HPV E6 and E7 Signaling

Area of Science:

• Oncology
• Virology
• Molecular Biology

Background:

• Cervical cancer, primarily caused by human papillomavirus (HPV), presents a significant global health challenge.
• HPV oncoproteins E6 and E7 are key drivers of cervical cancer development.
• The role of T-box transcription factor 3 (TBX3) in cervical cancer is not well understood.

Purpose of the Study:

• To investigate the expression and function of TBX3 in cervical cancer.
• To determine the relationship between TBX3, HPV infection, and cervical tumor progression.
• To evaluate TBX3 as a potential therapeutic target in HPV-positive cervical cancer.

Main Methods:

• Analysis of TBX3 expression in cervical cancer cell lines, precancerous tissues, and patient tumors.
• Utilizing knockdown and overexpression cell culture models to assess TBX3's functional impact.
• Investigating the dependency of TBX3's tumor-promoting activity on HPV E6/E7 oncoproteins.

Main Results:

• TBX3 is upregulated in cervical cancer tissues and cell lines, correlating with tumor size and invasiveness.
• TBX3 enhances proliferation, migration, and spheroid growth in HPV-positive cervical cancer cells.
• TBX3's tumor-promoting effects in cervical cancer are dependent on the presence of HPV E6/E7 oncoproteins.

Conclusions:

• TBX3 is a critical cooperating factor with HPV E6/E7 in the development of cervical cancer.
• TBX3 represents a promising therapeutic target for HPV-positive cervical cancer.